FDA Chief Scientist Schwetz May Have Larger Role Under Henney
This article was originally published in The Tan Sheet
Executive Summary
FDA Interim Chief Scientist and National Center for Toxicology Research Director Bernard Schwetz, PhD, may play a more prominent role at FDA under Commissioner Jane Henney, MD.
You may also be interested in...
FDA Senior Scientist Schwetz Named Acting Deputy Commissioner
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent successor for the office vacated by Michael Friedman, MD.
FDA Senior Scientist Schwetz Named Acting Deputy Commissioner
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent successor for the office vacated by Michael Friedman, MD.
FDA Senior Scientist Schwetz Named Acting Deputy Commissioner
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent successor for the office vacated by Michael Friedman, MD.